Business Context and Reporting Period
This Form 8-K was filed by TransBiotec, Inc. (not SOBR Safe, Inc., which appears to be a product or subsidiary reference) on April 19, 2016, reporting an event that occurred on April 7, 2016. The company is a Delaware corporation headquartered in Santa Ana, California.
Key Financial Metrics
The filing does not provide specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The report focuses solely on a specific business event.
Material Changes
The primary material event reported is the receipt of a purchase order from the company's distributor, AG Global Capital. The order is for 250 units of the company's SOBR Ignition Interlock device.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of risks and contingencies beyond the standard disclaimer that the press release information is not deemed "filed" under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the total contract value associated with the 250-unit purchase order from AG Global Capital.
- Confirm the expected delivery timeline and revenue recognition schedule for these units.
- Review the company's recent 10-K or 10-Q filings for baseline revenue and liquidity data, as this 8-K contains none.
- Assess the strategic importance of AG Global Capital as a distributor relative to the company's total sales volume.